Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8245103 | 0.94 | ADRB3 (0.36) | ADRB3ADRA2BADRA2CCYP3A4CTSS | |
| SCHEMBL13059696 | 0.94 | ADRB3 (0.36) | ADRB3ADRA2BADRA2CCYP3A4CTSS | |
| SCHEMBL12808087 | 0.89 | CYP3A4 (0.32) | ADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL13711314 | 0.88 | CTSB (0.38) | ADRB3ADRA2BADRA2CCYP3A4CTSS | |
| SCHEMBL11976325 | 0.86 | CYP3A4 (0.36) | ADRB3ADRA2BADRA2CCYP3A4CTSS | |
| SCHEMBL13059693 | 0.86 | CYP3A4 (0.36) | ADRB3ADRA2BADRA2CCYP3A4CTSS | |
| SCHEMBL12807925 | 0.85 | CYP3A4 (0.34) | ADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL13711289 | 0.85 | CYP3A4 (0.33) | ADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL11984068 | 0.85 | CYP3A4 (0.34) | ADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL13059745 | 0.85 | CYP3A4 (0.34) | ADRB3ADRA2BADRA2CCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2103623-A2 | Novel macrocyclic inhibitors of Hepatitis C virus replication | Intermune, Inc. (US) | 2009-09-23 | — | — | EP | disclosed |